Radiopharm Theranostics (ASX:RAD) Announces Q4 2024 Results
Radiopharm Theranostics (ASX:RAD) reports key approvals, financial updates, and upcoming clinical initiatives for Q4 2024.
Radiopharm Theranostics (ASX:RAD) reports key approvals, financial updates, and upcoming clinical initiatives for Q4 2024.
Gullewa Limited reports a positive cash flow for Q2 December 2024, with a focus on operational and financial strengths.
Pureprofile Limited upgrades its FY25 financial guidance following strong revenue growth in H1 and Q2 FY25 across all regions.
A1 Investments & Resources Limited reports $14,000 cash at quarter-end and outlines plans for future acquisitions and funding.
Terramin Australia Ltd (ASX:TZN) reports key milestones in project advancements, legal developments, and financial performance in its December 2024 quarterly report.
Vection Technologies (ASX:VR1) reports positive cash flow and significant revenue growth in its Q2 2025 results.
Winsome Resources (ASX:WR1) has entered partnerships to develop Carbon Dioxide Removal strategies, integrating sustainable practices into mining operations.
Singular Health Group (ASX: SHG) reports key partnerships, equity raise success, and a solid cash position as of December 31, 2024.
FlexiRoam Limited (ASX: FRX) reports a cash flow update for Q2 FY25, highlighting a strategic focus on sustainable growth and operational efficiencies.
IDT Australia Limited (ASX:IDT) reports an 82% revenue increase, primarily driven by growth in the Advanced Therapies business segment.